Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Sandy, Lepp"'
Autor:
Sandy Lepp, Erick Gamelin, Merrill J. Egorin, Gérard Milano, Salvatore J. Salamone, Rebecca L. Harney, Gregory D. Lundell, M. Boisdron-Celle, Catherine A. Hammett-Stabler, Yunying Li, Jodi Blake Courtney, Jan H. Beumer, Gwen McMillin, William Clarke
Publikováno v:
Therapeutic Drug Monitoring. 31:688-694
Background:5-Fluorouracil (5-FU) is the most widely used chemotherapy drug, primarily against gastrointestinal, head and neck, and breast cancers. 5-FU has large pharmacokinetic variability resulting in unexpected toxicity or ineffective treatment. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7db2ce134e020890d5e44ebbce68c90
https://doi.org/10.1097/ftd.0b013e3181b9b8c0
https://doi.org/10.1097/ftd.0b013e3181b9b8c0
Autor:
Jan H, Beumer, M, Boisdron-Celle, William, Clarke, Jodi B, Courtney, Merrill J, Egorin, Erick, Gamelin, Rebecca L, Harney, Catherine, Hammett-Stabler, Sandy, Lepp, Yunying, Li, Gregory D, Lundell, Gwen, McMillin, Gerard, Milano, Salvatore J, Salamone
Publikováno v:
Therapeutic drug monitoring. 31(6)
5-Fluorouracil (5-FU) is the most widely used chemotherapy drug, primarily against gastrointestinal, head and neck, and breast cancers. 5-FU has large pharmacokinetic variability resulting in unexpected toxicity or ineffective treatment. Therapeutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e6fd706609b1375cf360852286e450a1
https://pubmed.ncbi.nlm.nih.gov/19935361
https://pubmed.ncbi.nlm.nih.gov/19935361